Literature DB >> 29119181

Ligand directed structural diversity and magnetism in copper(ii)-azido assemblies with isomeric aminopyridines: synthesis, structure, magnetism and theoretical studies.

Priyanka Pandey1, Bhagwan Kharediya, Bahjat Elrez, J-P Sutter, G Bhargavi, M V Rajasekharan, Sailaja S Sunkari.   

Abstract

Four new copper complexes, viz. [{Cu(2-aminopyridine)(N3)2(H2O)}2]n (1), [Cu3(3-aminopyridine)2(N3)6]n (2), [{Cu(3-aminopyridine)(N3)2}2]n (3), and [Cu(4-aminopyridine)2(N3)2]n (4), have been synthesized with isomeric aminopyridines, viz. 2-aminopyridine (2-ap), 3-aminopyridine (3-ap), and 4-aminopyridine (4-ap), to probe the role of ligand and reactant molar ratios in directing the polynuclear assemblage and the associated magnetic properties. Ligand geometry is quite influential as can be seen through the versatile structures formed, viz. a hydrogen bonded layer of μ-1,1 azide bridged Cu dimers in 1; a network of two different types of dimers (Cu1-Cu2 & Cu3-Cu3') involving μ-1,1; μ-1,3; μ-1,1,3; & μ-1,1,3,3 azide bridges in 2; a ladder structure in which μ-1,1 azide bridges form the rungs and μ-1,3 azide bridges form the rails of the ladder in 3; and a 1-D polymer chain involving μ-1,1 azide bridges in 4. Consistent with the bridge geometry, compounds 1 & 2 display ferromagnetic interactions, while 3 & 4 display antiferromagnetic interactions. The rather unexpected antiferromagnetic interactions in 3, in spite of μ-1,1 azide bridged rungs may be due to the crossover near the bridge angle. The ferromagnetic interactions in 1 and 2 are supported by DFT calculations.

Entities:  

Year:  2017        PMID: 29119181     DOI: 10.1039/c7dt03115g

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  Structural Insights into Influence of Isomerism on Properties of Open Shell Cobalt Coordination System.

Authors:  Marcin Swiatkowski; Tomasz Sieranski; Marta Bogdan; Rafal Kruszynski
Journal:  Molecules       Date:  2019-09-16       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.